Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72722 record(s)

Req # A-2019-000873

Letter from Therapeutic Products Directorate to Ranbaxy certifying that the examination of RAN-Sildenafil (25, 50, 100 mg) was complete, approved and a Notice of Compliance would not be issued until the requirements of the Patented Medicines (NOC)…

Organization: Health Canada

2 page(s)
February 2021

Req # A-2019-001350

Multiple Adverse Drug Reaction (ADR) reports for IXAZOMIB.

Organization: Health Canada

715 page(s)
February 2021

Req # A-2020-000346

More information on the following recall: https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/72167r-eng.php Namely, what the established barium limit is and what this recalled product was tested at.

Organization: Health Canada

22 page(s)
February 2021

Req # A-2020-000808

All documents, including e-mails, texts or Instant messages, slack messages, WhatsApp messages, briefing notes, memos, reports, media lines, etc., regarding Health Canada’s Twitter account re-tweeting and then removing the re-tweets for certain…

Organization: Health Canada

16 page(s)
February 2021

Req # A-2020-000946

Information for how many applications have been filed and currently are pending for an Exemption To Use A Controlled Substance. Also how many approvals have been made for exemption of Section 56(1) for sacrament use.

Organization: Health Canada

1 page(s)
February 2021

Req # A-2020-001058

Records regarding the processing of access to information requests during the COVID-19 pandemic involving the Minister of Health, Minister’s Staff, and the Minister’s Office from July 1, 2020 to November 2, 2020.

Organization: Health Canada

56 page(s)
February 2021

Req # A-2020-001156

All documents and internal/external communication regarding a contract worth $371,318,000 and a contract worth $17,498,050 awarded to Proline Advantage Inc. from February 1, 2020 to November 13, 2020.

Organization: Health Canada

7 page(s)
February 2021

Req # A-2020-001210

All records to Health Canada from Novartis or submissions made by Novartis to Health Canada concerning the standards and criteria that should be applied by Health Canada when assessing the bioequivalence and/or bioavailability of octreotide acetate…

Organization: Health Canada

0 page(s)
February 2021

Req # A-2020-001416

All records, sent/rec'd by officials the Director General (DG), Assistant Deputy Minister (ADM) or Deputy Minister (DM) level regarding the contract with Proline Advantage Inc detailed in this news story https://www.cbc.ca/news/business/ppe-…

Organization: Health Canada

0 page(s)
February 2021

Req # A-2020-001417

The final versions of all Briefing Notes regarding Elmiron.

Organization: Health Canada

8 page(s)
February 2021
Date modified: